Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Mlecnik

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Seminars in Immunopathology|April 5, 2011
The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Oncoimmunology|September 14, 2020
Metastasis immune-based scores predict patient survivalBernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, et al.
Oncoimmunology|October 28, 2020
Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patientsPamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, et al.
Oncoimmunology|January 18, 2021
Multiverse of immune microenvironment in metastatic colorectal cancerMarc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Current Opinion in Immunology|March 9, 2010
Natural immunity to cancer in humansGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Atherosclerosis|February 24, 2006
LPL-mediated lipolysis of VLDL induces an upregulation of AU-rich mRNAs and an activation of HuR in endothelial cellsMarisa M O Tschernatsch, Bernhard Mlecnik, Zlatko Trajanoski, et al.
Bioinformatics (Oxford, England)|April 15, 2003
Client-server environment for high-performance gene expression data analysisAlexander Sturn, Bernhard Mlecnik, Roland Pieler, et al.
Oncotarget|October 6, 2015
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancerSandra Schmitz, Gabriela Bindea, Roxana Irina Albu, et al.
Oncoimmunology|May 3, 2014
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapyGautier Stoll, David Enot, Bernhard Mlecnik, et al.
Oncotarget|June 11, 2015
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignanciesGautier Stoll, Gabriela Bindea, Bernhard Mlecnik, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Seminars in Immunopathology|April 5, 2011
The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Oncoimmunology|September 14, 2020
Metastasis immune-based scores predict patient survivalBernhard Mlecnik, Gabriela Bindea, Marc Van den Eynde, et al.
Oncoimmunology|October 28, 2020
Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patientsPamela Baldin, Marc Van den Eynde, Bernhard Mlecnik, et al.
Oncoimmunology|January 18, 2021
Multiverse of immune microenvironment in metastatic colorectal cancerMarc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, et al.
Current Opinion in Immunology|March 9, 2010
Natural immunity to cancer in humansGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Atherosclerosis|February 24, 2006
LPL-mediated lipolysis of VLDL induces an upregulation of AU-rich mRNAs and an activation of HuR in endothelial cellsMarisa M O Tschernatsch, Bernhard Mlecnik, Zlatko Trajanoski, et al.
Bioinformatics (Oxford, England)|April 15, 2003
Client-server environment for high-performance gene expression data analysisAlexander Sturn, Bernhard Mlecnik, Roland Pieler, et al.
Oncotarget|October 6, 2015
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancerSandra Schmitz, Gabriela Bindea, Roxana Irina Albu, et al.
Oncoimmunology|May 3, 2014
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapyGautier Stoll, David Enot, Bernhard Mlecnik, et al.
Oncotarget|June 11, 2015
Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignanciesGautier Stoll, Gabriela Bindea, Bernhard Mlecnik, et al.
Pageof 7